For those interested - Eli Lilly has just released Q1 numbers...
here's the Axiron result:
Column 1 Column 2 0 Axiron Q1 1 US 35.6 2 Intl 1.4 3 Total US$ 37.0
https://investor.lilly.com/common/d...DF0B7C8C3B0&filename=IR_workbook_Q1_2016.xlsx
down on Q4 15 by c. 11% and down on Q1 15 by c. 5%... a little disappointing not showing growth - the q's over the last 24 months look to be bouncing between the high 30's and mid 40's... only positive takeaway is the Axiron div should still be okay if this number range continues.
Q1 Result
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 108241 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 50000 | 1 |
View Market Depth
| Last trade - 13.01pm 10/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable